Skip To The Main Content

PDA Europe Webinar - The Chemistry of Nitrosamines – Implications for Risk Assessment

Aug 27, 2020
4:00 PM
5:30 PM
| Central Europe Standard Time
  • Webinar
  • Virtual
  • Europe
  • Online


Chemistry and Risk Assessment of N-nitrosamines with Focus on Drug Product and Elastomeric Primary Packaging Components

Dear Colleagues,

Since their discovery in June 2018, nitrosamines have received a lot of attention amongst global pharmaceutical industry. Recent decisions from regulatory bodies involve the development of a risk assessment and a possible reduction and control of nitrosamines in the final drug product by the marketing authorization holder. Now, we have all been allowed extra time for the preparation of the risk assessment for the EDQM. But still, this topic is quite complex and there are several open questions.

In this webinar, we want to address some of the open questions, for example, how can we account for the specific chemistry of nitrosamines in the risk assessment and how play elastomeric components a role here?

This and more will be covered both from the perspectives of a pharmaceutical company as well as a rubber component supplier.


  • Welcome & Introductions

    Introduction to Nitrosamines:
    General Information and Current Regulatory Updates

    Bettine Boltres, WEST

    A Pharmaceutical Perspective:

    • Insights into the chemistry of nitrosamines
    • Focus on the drug product over the shelf-life
    • Implications for risk assessments
    Steve Baertschi, Consultant

    An Elastomeric Primary Packaging Perspective:

    • General composition & vulcanization
    • Raw materials and their potential connection to nitrosamines or their precursors
    • General nitrosamines analytics
    • Nitrosamine analytics on elastomer components
    Bettine Boltres, WEST
    How to Utilize Risk Assessment based on Components Results Steve Baertschi, Consultant
    Interactive Live Q&A and Discussion

Highlighted Speakers

Steven Baertschi
Steven Baertschi
Baertschi Consulting LLC
Bettine Boltres
Bettine Boltres
West Pharmaceutical Services

Registration Fees

Register Now
Registration Type Price
All Participants €199

Got a Question? We have answers

Contact Us
Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Information


Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information

Attendee List Email Scam

Unfortunately, emails are circulating that offer to sell attendee lists for many of PDA’s conferences and events. These emails are sent by scammers.

Note: PDA does not sell its exhibitor or attendee lists, and no third-party is authorized to distribute or sell any lists related to our events. Statements claiming to offer our attendee lists are fraudulent. If you receive emails that propose to sell PDA conference attendee lists, do not engage with the sender and delete the message immediately.

Media Partners

PDA Members Save Substantially